Emma P Halmos

Aug 10, 2023 | onlinelibrary.wiley.com | Sarah Melton |Emma P Halmos

The Low FODMAP diet (LFD) has become a mainstay in the management of irritable bowel syndrome (IBS) due to its high rates of symptom improvement. However, it is onerous and at least 30% of patients who follow the diet do not respond.1 The ability to predict and select those who are most likely to respond would be of great benefit in clinical practice and potentially avoid trialling a taxing diet.